| Name | Ibrutinib-MPEA |
|---|
| Description | Ibrutinib-MPEA (Compound 20) is ibrutinib derivative. Ibrutinib is a covalent and irreversible inhibitor of Bruton's tyrosine kinase (BTK) that has been used to treat haematological malignancies[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C32H39N9O2 |
|---|---|
| Molecular Weight | 581.71 |